Thymic epithelial tumors are a rare group of malignancies originating in the thymus gland, that includes thymoma and thymic ...

Kazuhisa Takahashi from Juntendo University, Japan, conducted the MARBLE study to evaluate the combination of atezolizumab, an immune checkpoint inhibitor, with carboplatin and paclitaxel in ...

BRACELET-1 results in HR+/HER2- metastatic breast cancer surpass expectations, providing meaningful data for a registration-enabling study Data from GOBLET in pancreatic ...

Q4 2024 Earnings Call Transcript March 7, 2025 Oncolytics Biotech Inc. beats earnings expectations. Reported EPS is $-0.06949, expectations were $-0.08. Operator: Good morning, and welcome to ...

nab-paclitaxel, and atezolizumab in first-line pancreatic ductal adenocarcinoma, enrolling the first patient in a registration-enabling study evaluating pelareorep and paclitaxel in advanced or ...